Verseon: Combining Deep Quantum Modeling™ and AI to Find Breakthrough Drugs

Verseon’s CEO Adityo Prakash discusses the role of the company’s Deep Quantum Modeling™ of protein-drug interactions with Pharmaceutical Executive’s Mike Hollan